Roswell Park Comprehensive Cancer Center Interventional Pulmonologist Nathaniel Ivanick, MD, Discusses Use of New Hybrid Metallic Y Stent to Treat a Severe Airway Obstruction Caused by a Malignant Lung Tumor
In this video, John M. Kane III, MD, FACS, chair of Surgical Oncology and Chief of the Melanoma/Sarcoma Service at Roswell Park, discusses some of the unique aspects of surgical oncology offered at the center and recent innovations in techniques
Chair of Thoracic Surgery at Roswell Park, Dr. Sai Yendamuri, shares insights into an exciting phase I trial evaluating the side effects of intraoperative photodynamic therapy with porfimer sodium in enhancing the response to immunotherapy ...
As the first to bring this technology to patients in New York State in July 2020, Dr. Ivanick has now performed more than 100 bronchoscopies using the platform, more than any other provider in New York State.
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy.
With lung cancer at the top of cancer-related deaths in Western New York — and at a rate higher than all of New York state — these experts from Roswell Park’s Community Outreach and Engagement team has been awarded funding from the Prevent ...
This site is intended for healthcare professionals